Selenium levels, selenoenzyme activities and oxidant/ antioxidant parameters in h1n1-infected children

Turkish Journal of Pediatrics

Volumn 55, Issue 3, 2013, Pages 271-282

  Erkekoǧlu, Pinar ^a   Ali, Aşçi ^a,b   Ceyhan, Mehmet ^c   Kizilgün, Murat ^d   Schweizer, Ulrich ^e   Ataş, Can ^f   Kara, Ateş ^c   Koçer Giray, Belma ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

^b ATATÜRK UNIVERSITY   (Turkey)

^c Sect Infect Dis Hacettepe U   (Turkey)

^d Oncology Research and Training Hospital   (Turkey)

^e CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^f UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Antioxidant enzymes; H1n1; Influenza; Lipid peroxidation; Selenium; Selenoenzymes

Indexed keywords

ANTIOXIDANT; C REACTIVE PROTEIN; CATALASE; ENZYME; GLUTATHIONE; GLUTATHIONE PEROXIDASE 1; GLUTATHIONE PEROXIDASE 3; GLUTATHIONE TRANSFERASE; SELENIUM; SELENOENZYME; SELENOPROTEIN P; SUPEROXIDE DISMUTASE; THIOREDOXIN REDUCTASE; UNCLASSIFIED DRUG;

ARTICLE; BLOOD LEVEL; CASE REPORT; CELL LEVEL; CHILD; CONTROLLED STUDY; DISEASE ASSOCIATION; DOWN REGULATION; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME LOCALIZATION; FEMALE; HUMAN; HUMAN CELL; INFLUENZA A (H1N1); LIPID PEROXIDATION; MALE; OUTCOME ASSESSMENT; OXIDATION REDUCTION STATE; SCHOOL CHILD;

ADOLESCENT; ANTIOXIDANTS; BIOLOGICAL MARKERS; CHILD; CHILD, PRESCHOOL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; HUMANS; INFANT; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; LIPID PEROXIDATION; MALE; OXIDANTS; RETROSPECTIVE STUDIES; SELENIUM; SELENOPROTEINS;

EID: 84883862826     PISSN: 00414301     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (73)

1. Bendich A. Antioxidant vitamins and human immune responses. Vitam Horm 1996; 52: 35-62.
2. Scrimshaw NS. Nutrition and infection. Prog Food Nutr Sci 1975; 1: 393-420.
3. Semba RD. Vitamin A, immunity, and infection. Clin Infect Dis 1994; 19: 489-499.
4. Beck MA, Levander OA. Dietary oxidative stress and the potentiation of viral infection. Annu Rev Nutr 1998; 18: 93-116.
5. Beck MA, Levander OA, Handy J. Selenium deficiency and viral infection. J Nutr 2003; 133: 1463S-1467S.
6. Flohé L. The glutathione peroxidase reaction: molecular basis of the antioxidant function of selenium in mammals. Curr Top Cell Regul 1985; 27: 473-478.
7. Avissar N, Whitin JC, Allen PZ, et al. Plasma selenium-dependent glutathione peroxidase. Cell of origin and secretion. J Biol Chem 1989; 264: 15850-15855.
8. Deisseroth A, Dounce AL. Catalase: physical and chemical properties, mechanism of catalysis, and physiological role. Physiol Rev 1970; 50: 319-375.
9. Spallholz JE, Boylan LM, Larsen HS. Advances in understanding selenium's role in the immune system. Ann N Y Acad Sci 1990; 587: 123-139.
10. Arthur JR, McKenzie RC, Beckett GJ. Selenium in the immune system. J Nutr 2003; 133: 1457S-1459S.
11. Baum MK, Shor-Posner G, Lai S, et al. High risk of HIV-related mortality is associated with selenium deficiency. J Acquir Immune Defic Syndr Hum Retrovirol 1997; 15: 370-374.
12. Dworkin BM. Selenium deficiency in HIV infection and the acquired immunodeficiency syndrome (AIDS). Chem Biol Interact 1994; 91: 181-186.
13. Harthill M. Review: micronutrient selenium deficiency influences evolution of some viral infectious diseases. Biol Trace Elem Res 2011; 143: 1325-1336.
14. Sheridan PA, Zhong N, Carlson BA, et al. Decreased selenoprotein expression alters the immune response during influenza virus infection in mice. J Nutr 2007; 137: 1466-1471.
15. Kiremidjian-Schumacher L, Stotzky G. Selenium and immune responses. Environ Res 1987; 42: 277-303.
16. Hincal F, Yetgin S, Ataçeri N. Selenium status in Turkey I. Serum selenium levels in infants and children in Ankara. Biol Trace Elem Res 1989; 20: 161-167.
17. Hincal F, Basaran N, Yetgin S, Gokmen O. Selenium status in Turkey I. Serum selenium concentration in healthy residents of different ages of Ankara. J Trace Elem Electrolytes Health Dis 1994; 8: 9-12.
18. Giray B, Hincal F, Teziç T, Okten A, Gedik Y. Status of selenium and antioxidant enzymes of goitrous children is lower than healthy controls and nongoitrous children with high iodine deficiency. Biol Trace Elem Res 2001; 82: 35-52.
19. Giray B, Hincal F. Plasma selenium levels in healthy adults living in rural areas of Turkey. In: Hincal F, Cavdar A, Giray B (eds). Selenium in Health and Disease (Proceedings of the International Symposium in Health and Disease, October 12-13, 2006). Ankara: Pozitif Press; 2006: 51-65.
20. Bender BS, Small PA Jr. Influenza: pathogenesis and host defense. Semin Respir Infect 1992; 7: 38-45.
21. Chan M. World now at the start of 2009 influenza pandemic. Statement to the press by WHO Director-General Dr Margaret Chan. Available at: http://who.int/mediacentre/news/statements/2009/h1n1_pandemic_ phase6_20090611/en/index.html.
22. Ramsey C, Kumar A. H1N1: viral pneumonia as a cause of acute respiratory distress syndrome. Curr Opin Crit Care 2011; 17: 64-71.
23. Çiftçi E, Tuygun N, Özdemir H, et al. Clinical and epidemiological features of Turkish children with 2009 pandemic influenza A (H1N1) infection: experience from multiple tertiary paediatric centres in Turkey. Scand J Infect Dis 2011; 43: 923-929.
24. Nunes JA, Batista BL, Rodrigues JL, et al. A simple method based on ICP-MS for estimation of background levels of arsenic, cadmium, copper, manganese, nickel, lead, and selenium in blood of the Brazilian population. J Toxicol Environ Health A 2010; 73: 878-887.
25. Flohé L, Günzler WA. Assays of glutathione peroxidase. Methods Enzymol 1984; 105: 114-121.
26. Günzler WA, Kremers H, Flohé L. An improved coupled test procedure for glutathione peroxidase (EC 1-11-1-9-) in blood. Z Klin Chem Klin Biochem 1974; 12: 444-448.
27. Arnér ES, Zhong L, Holmgren A. Preparation and assay of mammalian thioredoxin and thioredoxin reductase. Methods Enzymol 1999; 300: 226-239.
28. Aebi H. Catalase. In: Bergmeyer HU (ed). Methods of Enzymatic Analysis. New York: Academic Press; 1974: 673-677.
29. Marklund S, Marklund G. Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur J Biochem 1974; 47: 469-474.
30. Habig WH, Pabst MJ, Jakoby WB. Glutathione S-transferases. The first enzymatic step in mercapturic acid formation. J Biol Chem 1974; 249: 7130-7139.
31. Akerboom T P, Sies H. Assay of glutathione, glutathione disulfide, and glutathione mixed disulfides in biological samples. Methods Enzymol 1981; 77: 373-382.
32. Templar J, Kon S P, Milligan T P, et al. Increased plasma malondialdehyde levels in glomerular disease as determined by a fully validated HPLC method. Nephrol Dial Transplant 1999; 14: 946-951.
33. Hollenbach B, Morgenthaler NG, Struck J, et al. New assay for the measurement of selenoprotein P as a sepsis biomarker from serum. J Trace Elem Med Biol 2008; 22: 24-32.
34. Eckerlin RH, Hoult DW, Carnrick GR. Selenium determination in animal whole blood using stabilized temperature platform furnace and Zeeman background correction. At Spectrosc 1987; 8: 64-66.
35. Scrimshaw NS. Nutrition and infection. Prog Food Nutr Sci 1975; 1: 393-420.
36. Semba RD. Vitamin A, immunity, and infection. Clin Infect Dis 1994; 19: 489-499.
37. Bendich A. Physiological role of antioxidants in the immune system. J Dairy Sci 1993; 76: 2789-2794.
38. Beck MA. Antioxidants and viral infections: host immune response and viral pathogenicity. J Am Coll Nutr 2001; 20: 384S-388S.
39. Thompson D, Pepys MB, Wood S P. The physiological structure of human C-reactive protein and its complex with phosphocholine. Structure 1999; 7: 169-177.
40. Pepys MB, Hirschfield GM. C-reactive protein: a critical update. J Clin Invest 2003; 111: 1805-1812.
41. Ni Z, Guo Z, Chen X, et al. Cardiac injury in patients with pandemic 2009 influenza A (H1N1) infection. Acta Cardiol 2011; 66: 427-432.
42. Song J Y, Cheong HJ, Heo JY, et al. Clinical, laboratory and radiologic characteristics of 2009 pandemic influenza A/H1N1 pneumonia: primary influenza pneumonia versus concomitant/secondary bacterial pneumonia. Influenza Other Respi Viruses 2011; 5: e535-e543.
43. Sies H. Oxidative stress: oxidants and antioxidants. Exp Physiol 1997; 82: 291-295.
44. Davies KJ. Oxidative stress: the paradox of aerobic life. Biochem Soc Symp 1995; 61: 1-31.
45. Halliwell B. Oxidative stress, nutrition and health. Experimental strategies for optimization of nutritional antioxidant intake in humans. Free Radic Res 1996; 25: 57-74.
46. Stadtman TC. Selenium biochemistry. Mammalian selenoenzymes. Ann N Y Acad Sci 2000; 899: 399-402.
47. Fairweather-Tait SJ, Bao Y, Broadley MR, et al. Selenium in human health and disease. Antioxid Redox Signal 2011; 14: 1337-1383.
48. Broome CS, McArdle F, Kyle JA, et al. An increase in selenium intake improves immune function and poliovirus handling in adults with marginal selenium status. Am J Clin Nutr 2004; 80: 154-162.
49. Reid ME, Duffield-Lillico AJ, Sunga A, et al. Selenium supplementation and colorectal adenomas: an analysis of the nutritional prevention of cancer trial. Int J Cancer 2006; 118: 1777-1781.
50. Nelson HK, Shi Q, Van Dael P, et al. Host nutritional selenium status as a driving force for influenza virus mutations. FASEB J 2001; 15: 1846-1848.
51. Boyne R, Arthur JR, Wilson AB. An in vivo and in vitro study of selenium deficiency and infection in rats. J Comp Pathol 1986; 96: 379-386.
52. Li W, Beck MA. Selenium deficiency induced an altered immune response and increased survival following influenza A/Puerto Rico/8/34 infection. Exp Biol Med (Maywood) 2007; 232: 412-419.
53. Jaspers I, Zhang W, Brighton LE, et al. Selenium deficiency alters epithelial cell morphology and responses to influenza. Free Radic Biol Med 2007; 42: 1826-1837.
54. Beck MA. Nutritionally induced oxidative stress: effect on viral disease. Am J Clin Nutr 2000; 71: 1676S-1681S.
55. Manzanares W, Biestro A, Galusso F, et al. Serum selenium and infection in rats. J Comp Pathol 1986; 96: 379-386.
56. Greenman E, Phillipich MJ, Meyer CJ, et al. The effect of selenium glutathione peroxidase-3 activity: biomarkers of systemic inflammation in the critically ill? Intensive Care Med 2009; 35: 882-889.
57. Arteel GE, Klotz LO, Buchczyk D P, et al. Selenoprotein P. Methods Enzymol 2002; 347: 121-125.
58. Saito Y, Takahashi K. Characterization of selenoprotein P as a selenium supply protein. Eur J Biochem 2002; 269: 5746-5751.
59. Forceville X, Mostert V, Pierantoni A, et al. Selenoprotein P, rather than glutathione peroxidase, as a potential marker of septic shock and related syndromes. Eur Surg Res 2009; 43: 338-347.
60. Hollenbach B, Morgenthaler NG, Struck J, et al. New assay for the measurement of selenoprotein P as a sepsis biomarker from serum. J Trace Elem Med Biol 2008; 22: 24-32.
61. Shi XL, Shi ZH, Huang H, et al. Therapeutic effect of recombinant human catalase on H1N1 influenza-induced pneumonia in mice. Inflammation 2010; 33: 166-172.
62. Choi AM, Knobil K, Otterbein SL, et al. Oxidant stress responses in influenza virus pneumonia: gene expression and transcription factor activation. Am J Physiol 1996; 271: L383-L391.
63. Case AJ, McGill JL, Tygrett LT, et al. Elevated mitochondrial superoxide disrupts normal T cell development, impairing adaptive immune responses to an influenza challenge. Free Radic Biol Med 2011; 50: 448-458.
64. Sidwell RW, Huffman JH, Bailey K W, et al. Inhibitory effects of recombinant manganese superoxide dismutase on influenza virus infections in mice. Antimicrob Agents Chemother 1996; 40: 2626-2631.
65. Cai J, Chen Y, Seth S, et al. Inhibition of influenza infection by glutathione. Free Radic Biol Med 2003; 34: 928-936.
66. Uchide N, Toyoda H. Antioxidant therapy as a potential approach to severe influenza-associated complications. Molecules 2011; 16: 2032-2052.
67. Geiler J, Michaelis M, Naczk P, et al. N-acetyl-L-cysteine (NAC) inhibits virus replication and expression of pro-inflammatory molecules in A549 cells infected with highly pathogenic H5N1 influenza A virus. Biochem Pharmacol 2010; 79: 413-420.
68. Ungheri D, Pisani C, Sanson G, et al. Protective effect of n-acetylcysteine in a model of influenza infection in mice. Int J Immunopathol Pharmacol 2000; 13: 123-128.
69. De Flora S, Grassi C, Carati L. Attenuation of influenzalike symptomatology and improvement of cell-mediated immunity with long-term N-acetylcysteine treatment. Eur Respir J 1997; 10: 1535-1541.
70. Lai KY, Ng WY, Osburga Chan PK, et al. High-dose N-acetylcysteine therapy for novel H1N1 influenza pneumonia. Ann Intern Med 2010; 152: 687-688.
71. Catalá A. Lipid peroxidation of membrane phospholipids generates hydroxy-alkenals and oxidized phospholipids active in physiological and/or pathological conditions. Chem Phys Lipids 2009; 157: 1-11.
72. Mileva M, Bakalova R, Tancheva L, et al. Effect of vitamin E supplementation on lipid peroxidation in blood and lung of influenza virus infected mice. Comp Immunol Microbiol Infect Dis 2002; 25: 1-11.
73. He RR, Wang M, Wang CZ, et al. Protective effect of apple polyphenols against stress-provoked influenza viral infection in restraint mice. J Agric Food Chem 2011; 59: 3730-3737.